Genentech announces positive results from a Phase IV study of Raptiva in patients with moderate-to-severe hand and foot psoriasis.(Product News)(Clinical report): An article from: Dermatology Nursing

This digital document is an article from Dermatology Nursing, published by Thomson Gale on April 1, 2007. The length of the article is 447 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Genentech announces positive results from a Phase IV study of Raptiva in patients with moderate-to-severe hand and foot psoriasis.(Product News)(Clinical report)
Author: Gale Reference Team
Publication:Dermatology Nursing (Magazine/Journal)
Date: April 1, 2007
Publisher: Thomson Gale
Volume: 19 Issue: 2 Page: 194(1)

Article Type: Clinical report

Distributed by Thomson Gale